SCTX — Scribe Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1853921 ·
Last close
$19.46
Market Cap
—
52W High
$25.49
52W Low
$17.31
ADV30
402,170
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,233,000 | — | -12,427,000 | -17,347,000 | 65,208,000 | 20,381,000 | 223,946,000 |
| Mar 2025 | 17,125,000 | — | -5,557,000 | -3,425,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,176,000
Investing CF
$36,469,000
Financing CF
$-413,000
CapEx
$-508,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-07-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-175,054,000
Inventory
—
Receivables
$1,521,000
ST Investments
$29,350,000
EBIT TTM
$-19,663,000
Pretax Income TTM
$-20,859,000
Interest Exp TTM
$1,196,000
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 51,174,000 | -26,070,000 | -21,808,000 | 78,219,000 | 221,638,000 | — | -45,213,000 |
| Dec 2024 | 27,413,000 | -42,829,000 | -47,786,000 | 127,971,000 | 253,830,000 | — | -45,235,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $207.87B | $385.16 | — |
| GILD | GILEAD SCIENCES, INC. | $161.66B | $130.21 | — |
| ARGX | ARGENX SE | $53.42B | $853.82 | — |
| RVMD | Revolution Medicines, Inc. | $39.87B | $187.53 | — |
| BIIB | BIOGEN INC. | $29.99B | $202.95 | — |
News headlines (Yahoo Finance, 1h cache)
Scribe’s Genetic Editing Aims to Prevent Heart Attacks
2026-07-30 14:26 · Yahoo
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
2026-07-27 20:05 · Yahoo
Scribe Therapeutics Soars 67% After $128.7 Million Upsized IPO
2026-07-24 18:45 · Yahoo
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
2026-07-24 01:08 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-07-29 18:47:29 | 2026-07-27 | Orbimed Advisors LLC | Dir | P - Purchase | 15 | 1000000 | 15000000 |
| 2026-07-29 18:50:42 | 2026-07-27 | Gordon Carl L | Dir | P - Purchase | 15 | 1000000 | 15000000 |
| 2026-07-29 19:09:52 | 2026-07-27 | Ah Bio Fund Ii, L.P. | 10% | P - Purchase | 15 | 333333 | 4999995 |
| 2026-07-28 21:30:16 | 2026-07-24 | Aghazadeh Behzad | See Remarks, 10% | P - Purchase | 15.16 | 2391238 | 36259761 |
| 2026-07-27 21:20:26 | 2026-07-23 | Parrot David | CFO | P - Purchase | 15 | 2666 | 39990 |
| 2026-07-27 21:42:12 | 2026-07-23 | Lucas Svetlana | Chief Business Officer | P - Purchase | 15 | 3000 | 45000 |